Prescription drug expenditures and population demographics

Health Services Research

Volumn 41, Issue 2, 2006, Pages 411-428

  Morgan, Steven G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

British Columbia; Demographics; Expenditures; Prescription drugs

Indexed keywords

ANTIINFECTIVE AGENT; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; GASTROINTESTINAL AGENT; SEX HORMONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANADA; CHILD; COST BENEFIT ANALYSIS; DEMOGRAPHY; DRUG COST; DRUG INFORMATION; DRUG UTILIZATION; FEMALE; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PHARMACY; PRESCRIPTION; PUBLIC HEALTH; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DEMOGRAPHY; DRUG UTILIZATION; FEES, PHARMACEUTICAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PRESCRIPTION FEES; SEX FACTORS;

EID: 33644860222     PISSN: 00179124     EISSN: 14756773     Source Type: Journal    
DOI: 10.1111/j.1475-6773.2005.00495.x     Document Type: Article

References (25)

1. Anderson GF. DG. Shea PS. Hussey S. Keyhani L. Zephyrin 2004 MarketWatch Doughnut Holes and Price Controls Health Affairs (Millwood) 23 Suppl. 2 396 404
2. Applied Management, Fraser Group, and Tristat Resources 2000 Canadians' Access to Insurance for Prescription Medicines Vol. 2 Ottawa Health Canada, Health Transition Fund
3. Barer ML. RG. Evans C. Hertzman 1995 Avalanche or Glacier? Health Care and the Demographic Rhetoric Canadian Journal on Aging 14 2 193 224
4. Berndt ER. 2001 The U.S. Pharmaceutical Industry Why Major Growth in Times of Cost Containment? Health Affairs 20 2 100 14
5. British Columbia 2001 Pharmacare Trends 2000 56pp Victoria Pharmacare, Ministry of Health Services [Available at accessed July 23, 2003]
6. Diewert WE. 1993 The Economic Theory of Index Numbers A Survey In Essays in Index Number Theory Vol. 1 edited by Diewert WE. Nakamura AO. Amsterdam Elsevier Science
7. Evans RG. 1985 Illusions of Necessity Evading Responsibility for Choice in Health Care Journal of Health Politics, Policy and Law 10 3 439 67
8. Evans RG. KM. McGrail SG. Morgan ML. Barer C. Hertzman 2001 APOCALYPSE NO Population Aging and the Future of Health Care Systems Canadian Journal on Aging 20 suppl 1 160 91
9. Foot DK. D. Stoffman 1998 Boom, Bust & Echo 2000: Profiting from the Demographic Shift in the New Millennium Toronto Macfarlane Walter & Ross
10. Fuchs VR. 1984 'Though Much Is Taken' Reflections on Aging, Health, and Medical Care Milbank Memorial Fund Quarterly Health Society 62 2 143 66
11. George MV. Statistics Canada, Demography Division 2001 Population Projections for Canada, Provinces and Territories, 2000-2026 (Projections démographiques pour le Canada, les provinces et les territoires, 2000-2026) Ottawa Statistics Canada=Statistique Canada
12. Gerdtham UG. D. Lundin 2004 Changes in Drug Spending for Different Age Groups during the 1990s? Evidence from Sweden Expert Review of Pharmacoeconomics and Outcomes Research 4 3 343 51
13. IMS 2004 "Global Pharmaceutical Sales by Region, 2000-2003" [accessed on May 4, 2004]. Available at
14. Marshall T. 2003 Coronary Heart Disease Prevention Insights from Modelling Incremental Cost Effectiveness British Medical Journal 327 7426 1264 70
15. Merlis M 2000. "Explaining the Growth in Prescription Drug Spending: A Review of Recent Studies." Report prepared for the U.S. Department of Health and Human Services, Conference on Pharmaceutical Pricing Practices, Utilization and Costs, August.
16. Metge C. C. Black S. Peterson AL. Kozyrskyj 1999 The Population's Use of Pharmaceuticals Medical Care 37 6 suppl JS42 59
17. Morgan SG. 2002 Quantifying Components of Drug Expenditure Inflation The British Columbia Seniors' Drug Benefit Plan Health Services Research 37 5 1243 66
18. Morgan SG. ML. Barer JD. Agnew 2003 Whither Seniors' Pharmacare Lessons from (and for) Canada Health Affairs (Millwood) 22 3 49 59
19. Morgan S. P. Schaub D. Mooney P. Caetano S. Rahim-Jamal M. McMahon L. Yan 2005 "Mapping Drug Utilization Patterns: A Canadian Case Study," 2005 Annual Research Meeting of Academy Health, Boston.
20. Mueller C. C. Schur J. O'Connell 1997 Prescription Drug Spending The Impact of Age and Chronic Disease Status American Journal of Public Health 87 10 1626 29
21. Reinhardt UE. 2003 Does the Aging of the Population Really Drive the Demand for Health Care? Health Affairs 22 6 27 39
22. U.S. Census Bureau 2004 "U.S. Interim Projections by Age, Sex, Race, and Hispanic Origin" [accessed on Jan. 19, 2004]. Available at
23. U.S.A. 2003 Medicare Prescription Drug, Improvement, and Modernization Act One Hundred Eighth Congress of the United States of America
24. Van Tielen R. F. Peys J. Genaert 1998 The Demographic Impact on Ambulatory Pharmaceutical Expenditure in Belgium Health Policy 45 1 1 14
25. WHO 2004 Guidelines for ATC Classification and DDD Assignment 2004 Oslo, Norway WHO Collaborating Centre for Drug Statistics Methodology